Diarrhea News and Research

Latest Diarrhea News and Research

Data on ULORIC treatment for gout flares presented at the 73rd American College of Rheumatology meeting

Data presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology highlight effects of baseline characteristics on achievement of serum uric acid (sUA) levels to <6.0 mg/dL and the frequency of flares with ULORIC- (febuxostat) treatment.

20 Oct 2009

Optimer Pharmaceuticals to present additional data on fidaxomicin at the 47th IDSA meeting

Optimer Pharmaceuticals, Inc. announced that additional data related to fidaxomicin, the Company's lead developmental product candidate for the treatment of Clostridium difficile infection, will be presented at the 47th Annual Meeting of the Infectious Disease Society of America (IDSA) to be held at The Philadelphia Convention Center in Philadelphia, Pennsylvania October 29 through November 1, 2009.

20 Oct 2009

Celgene Corporation updates on Phase II study evaluating apremilast in psoriatic arthritis patients

Celgene Corporation announced that updated results of a phase II, multi-center, randomized, double-blind, placebo-controlled, three-arm study of apremilast in adult patients with psoriatic arthritis (CC-10004-PSA-001) were presented today at the American College of Rheumatology (ACR) 2009 annual meeting in Philadelphia, PA.

20 Oct 2009

FDA approves new oral medication for renal cell carcinoma

The U.S. Food and Drug Administration today approved Votrient (pazopanib), the sixth drug to be approved for kidney cancer since 2005.

20 Oct 2009

Philippines at risk for rapid spread of disease after typhoons

"Survivors of two powerful storms that caused widespread destruction in the Philippines in recent weeks are threatened by outbreaks of potentially life-threatening diseases, as the country braces for another super-typhoon," named Lupit, that is expected to make landfall on Thursday, the Guardian reports.

19 Oct 2009

URL Pharma's Colcrys approved by FDA for prevention of gout flares

URL Pharma, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Colcrys(TM) (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA on July 30, 2009 for the treatment of acute gout flares when taken at the first sign of a flare.

19 Oct 2009

Also in Global Health News: Asia-Pacific reproductive health; developing country medical waste disposal; draft bill in Uganda; diarrhea deaths in China

"China has called on Asia-Pacific countries to attach greater importance to population and family planning and put more funds into the reproductive health and family planning programmes," the Daily Times reports (10/19).

19 Oct 2009

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its angiotensin II receptor blocker (ARB) Micardis® (telmisartan) Tablets 80 mg for reduction of the risk of myocardial infarction, stroke, or death from cardiovascular causes in patients 55 years of age or older at high risk of developing major cardiovascular events who are unable to take angiotensin-converting enzyme (ACE) inhibitors.(1) MICARDIS is the most studied ARB in this high-risk patient population and has been commercially available to treat hypertension (high blood pressure) since its approval in 1998.

19 Oct 2009

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

New long-term data from two pivotal, Phase 3 clinical trials showed that patients with active rheumatoid arthritis (RA) receiving SIMPONI(TM) (golimumab) every four weeks achieved sustained improvements in signs and symptoms and physical function response through one year. These new data were presented today at the 2009 American College of Rheumatology (ACR) Annual Scientific Meeting.

19 Oct 2009

CONFIRMS trial demonstrates efficacy of ULORIC for treating hyperuricemia in patients with gout

19 Oct 2009

WHO, UNICEF publish plan to reduce childhood diarrhea deaths

The WHO and UNICEF have released a seven-point treatment and prevention plan to reduce the number of children around the world who die from diarrhea, the BBC reports (10/14). BMJ News writes, "Every year 1.5 million children aged under 5 years die from diarrhoea, more than 80% of them in Africa and south Asia" (Zarocostas, 10/14).

19 Oct 2009

FDA grants marketing approval for Elitek

Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Elitek (rasburicase) to be used for the initial management of plasma uric acid (PUA) levels in adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) and subsequent elevations of plasma uric acid.

19 Oct 2009

Over 80 countries mark world handwashing day

VOA News reports that more than 80 countries marked Global Handwashing Day Thursday. The news service writes that "[d]iarrhea is the third cause of death in West and Central Africa, which is responsible for 30 percent of the world's deaths of children under the age of five."

19 Oct 2009

CVS Caremark's seasonal flu shot clinics to run through October 22

CVS/pharmacy announced today that its seasonal flu shot clinics will run through October 22, in light of manufacturer delays in delivery of seasonal flu vaccine affecting all health care providers. However, MinuteClinic will continue to administer seasonal flu vaccines at its 500 locations in 25 states throughout the flu season with the supply of vaccine replenished as frequently as possible.

19 Oct 2009

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).

15 Oct 2009

UNICEF and WHO call for an urgent plan to control diarrheal disease

The United Nations Children’s Fund (UNICEF) and World Health Organization (WHO) released a joint report today demonstrating the urgent need to focus attention on diarrheal disease, a neglected illness responsible for the deaths of about 1.5 million children under 5 each year. This unacceptable loss of life can be stopped.

15 Oct 2009

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

A study, published online in the journal Current Medical Research and Opinion, showed that a greater percentage of patients with type 2 diabetes treated with the fixed-dose combination ACTOplus met® (pioglitazone HCl and metformin HCl) as initial therapy reached the study goal of hemoglobin A1c (HbA1c) of less than or equal to 7 percent compared to either component alone.

15 Oct 2009

Progenics Pharmaceuticals and Wyeth Pharmaceuticals sign license agreement

Progenics Pharmaceuticals, Inc. today announced that it has entered into an agreement with Wyeth Pharmaceuticals, a division of Wyeth under which Progenics is regaining all worldwide rights to the RELISTOR® franchise from Wyeth Pharmaceuticals, which Progenics had previously licensed to Wyeth Pharmaceuticals.

14 Oct 2009

Research scientists develop bioengineered treatment for targeting pancreatic cancer

Research scientists from Massachusetts General Hospital, Boston, have developed a novel bioengineered treatment that has shown promise in targeting pancreatic cancer without causing damage to healthy noncancer cells, a typical problem of chemotherapy.

14 Oct 2009

SCID infants who receive early bone marrow transplants are likely to have fewer complications

Mention the words "bubble boy" and many will recall David Vetter, the kid with big eyes and a thick thatch of dark hair who died 25 years ago after spending almost the entire 12 years of his life in a germ-free, plastic bubble. David was born with severe combined immune deficiency, or SCID, a condition that robbed him of an immune system.

14 Oct 2009

Diarrhea News and Research

Latest Diarrhea News and Research

Data on ULORIC treatment for gout flares presented at the 73rd American College of Rheumatology meeting

Optimer Pharmaceuticals to present additional data on fidaxomicin at the 47th IDSA meeting

Celgene Corporation updates on Phase II study evaluating apremilast in psoriatic arthritis patients

FDA approves new oral medication for renal cell carcinoma

Philippines at risk for rapid spread of disease after typhoons

URL Pharma's Colcrys approved by FDA for prevention of gout flares

Also in Global Health News: Asia-Pacific reproductive health; developing country medical waste disposal; draft bill in Uganda; diarrhea deaths in China

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

CONFIRMS trial demonstrates efficacy of ULORIC for treating hyperuricemia in patients with gout

WHO, UNICEF publish plan to reduce childhood diarrhea deaths

FDA grants marketing approval for Elitek

Over 80 countries mark world handwashing day

CVS Caremark's seasonal flu shot clinics to run through October 22

Soligenix commences enrollment in its Phase 3 Orbec clinical trial for acute GI GVHD

UNICEF and WHO call for an urgent plan to control diarrheal disease

Study shows type 2 diabetes patients treated with ACTOplus met experience blood sugar reduction

Progenics Pharmaceuticals and Wyeth Pharmaceuticals sign license agreement

Research scientists develop bioengineered treatment for targeting pancreatic cancer

SCID infants who receive early bone marrow transplants are likely to have fewer complications

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Diarrhea News and Research

Latest Diarrhea News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in